LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026)

LivaNova's (LIVN) quarterly Liabilities and Shareholders Equity came in at $2.5 billion in Q1 2026, down 1.66% year-on-year from $2.6 billion in Q1 2025, and down 3.44% quarter-over-quarter from $2.6 billion in Q4 2025.

LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

LivaNova has disclosed Liabilities and Shareholders Equity across 12 years of filings, most recently posting $2.5 billion for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $2.5 billion, down 1.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 billion (up 20.66% YoY), and the FY2025 annual result was $2.6 billion, up 3.98% from the prior year.
  • Liabilities and Shareholders Equity came in at $2.5 billion for Q1 2026 at LivaNova, down from $2.6 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.6 billion in Q4 2025 to a low of $855.1 million in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $2.4 billion (2023), against an average of $2.3 billion.
  • Across the five-year window, Liabilities and Shareholders Equity sank 63.48% in 2024 and surged 193.15% in 2025, its largest moves.
  • LivaNova's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then climbed by 5.87% to $2.4 billion in 2023, then increased by 3.16% to $2.5 billion in 2024, then climbed by 3.98% to $2.6 billion in 2025, then declined by 3.44% to $2.5 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $2.5 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 LivaNova 4.29 Bn 3.71 Bn 243.75 Mn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.52 Bn
Dec 31, 2025 2.61 Bn
Sep 30, 2025 2.56 Bn
Jun 30, 2025 2.51 Bn
Mar 31, 2025 2.56 Bn
Dec 31, 2024 2.51 Bn
Sep 30, 2024 2.52 Bn
Jun 30, 2024 855.10 Mn
Mar 31, 2024 2.46 Bn
Dec 31, 2023 2.43 Bn
Sep 30, 2023 2.33 Bn
Jun 30, 2023 2.34 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.29 Bn
Sep 30, 2022 2.21 Bn
Jun 30, 2022 2.34 Bn
Mar 31, 2022 2.42 Bn
Dec 31, 2021 2.20 Bn
Sep 30, 2021 2.20 Bn
Jun 30, 2021 2.40 Bn